Share on facebook
Facebook
Share on twitter
Twitter
Share on email
Email

3.4M workers get almost P30B in cash aid: DOLE

Share on facebook
Facebook
Share on twitter
Twitter
Share on email
Email

The government has provided close to P30-billion financial assistance to over three million local and overseas workers affected by coronavirus disease 2019 (Covid-19) pandemic, the Department of Labor and Employment said.

Assistant Secretary Dominique Tutay, in a Laging Handa briefing, said some P28.8 billion under the Bayanihan to Heal as One Act (Bayanihan 1) and the Bayanihan to Recover as One Act (Bayanihan 2) were allocated to extend cash aid to formal and informal sector employees and OFWs stranded here and displaced abroad.

“Under Bayanihan 1 and 2, we have about P28.8 billion financial assistance to some 3.4 million workers from the formal sector, informal sector, and also the repatriated OFWs,” she said.

Tutay was referring to the department’s three major programs – the Covid-19 Adjustment Measures Program (CAMP), Tulong Panghanapbuhay sa Ating Disadvantaged/Displaced Workers (TUPAD) Program, and the Abot Kamay ang Pagtulong (AKAP).

“For CAMP which is a one-time cash assistance worth P5,000, we were able to provide for 1.6 million workers from the formal sector,” she said.

“Under TUPAD, the emergency employment for the informal sector, we were able to assist 1.4 million informal sector workers,” the DOLE official added.

Tutay said the P10,000 (USD200) cash aid provided under AKAP helped 427,000 OFWs.

She reported that based on their monitoring, over 4 million workers in the country have been affected by the pandemic.

“Based on our monitoring on job displacement, more than 420,000 workers have permanently lost their jobs and there are 4.5 million workers affected by flexible work arrangement and temporary closure,” she said.*PNA

ARCHIVES

Read Article by date

April 2024
MTWTFSS
1234567
891011121314
15161718192021
22232425262728
2930 

Get your copy of the Visayan Daily Star everyday!

Avail of the FREE 30-day trial.